HTXD: Treatment: ARV Drugs |
$257,021,927 |
HTXS: Treatment: Adult Treatment |
$247,581,500 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission |
$116,160,281 |
HKID: Care: Orphans and Vulnerable Children |
$111,645,160 |
HLAB: Laboratory Infrastructure |
$111,052,330 |
OHSS: Health Systems Strengthening |
$96,933,250 |
HBHC: Care: Adult Care and Support |
$96,473,336 |
HVCT: Testing: HIV Testing and Counseling |
$84,114,368 |
HVMS: Management and Operations |
$72,465,368 |
HVOP: Sexual Prevention: Other Sexual Prevention |
$60,697,765 |
HVSI: Strategic Information |
$38,327,914 |
HVTB: Care: TB/HIV |
$29,837,843 |
PDTX: Treatment: Pediatric Treatment |
$27,201,931 |
PDCS: Care: Pediatric Care and Support |
$13,980,187 |
HMBL: Biomedical Prevention: Blood Safety |
$13,238,200 |
HVAB: Sexual Prevention: Abstinence/Be Faithful |
$10,622,347 |
HMIN: Biomedical Prevention: Injection Safety |
$8,489,136 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use |
$0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision |
$0 |